Senior insider sale
Sr VP, Drug Discovery at ADAPTIVE BIOTECHNOLOGIES CORP — senior position signals high conviction
$916.3K
63.10K shares
What this filing means
BENZENO SHARON plans to sell 63.10K shares of ADAPTIVE BIOTECHNOLOGIES CORP valued at approximately $916.3K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/16/2026ACC: 0001780854-26-000006
Officer· Sr VP, Drug Discovery
Since Jun 2019
63.10K
Shares to sell
$916.3K
Approx. market value
63.10K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted Stock Units
N/A
3/10/2026
63.10KTotal acquired63.10K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/10/2026 | Restricted Stock Units N/A | 63.10K | — |
| Total | 63.10K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
63.10K
Market value
$916.3K
3/11/2026
Total
Units
63.10K
Value
$916.3K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
3/11/2026 | 63.10K | $916.3K | NASDAQ | Planned |
| Total | 63.10K | $916.3K | ||